Genome-wide CRISPR-Cas9 screen identified KLF11 as a druggable suppressor for sarcoma cancer stem cellsYicun Wang, Le Qu, Bing Liu et al.|Science Advances|2021Cited by 41
miR-129 predicts prognosis and inhibits cell growth in human prostate carcinomaSong Xu, Wenquan Zhou|Molecular Medicine Reports|2016Cited by 26
Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombusYufeng Gu, Wenquan Zhou, Yao Fu et al.|Frontiers in Oncology|2023Cited by 14
Collecting Duct Carcinoma of the Kidney: A Single-Center Retrospective Study of 23 CasesChaopeng Tang, Wenquan Zhou, Jie Dong et al.|Technology in Cancer Research & Treatment|2023Cited by 6
Efficacy and safety of disitamab vedotin (RC48) combined with toripalimab as adjuvant therapy after radical surgery for patients with HER2-overexpression upper tract urothelial cancer (UTUC): A single-arm, prospective, phase 2 clinical trial.Shouyong Liu, Le Qu, Miao He et al.|Journal of Clinical Oncology|2025Cited by 2